Formoterol

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 3184 publications

Does asthma treatment influence COVID-19 severity? A comparative cohort study of SMART vs. Traditional therapy.

Does asthma treatment influence COVID-19 severity? A comparative cohort study of SMART vs. Traditional therapy.

Journal: European clinical respiratory journal

Published: June 10, 2026

Symptom Improvement with BDP/FF/G Fixed Triple Inhalation Powder in Moderate to Severe COPD Patients Uncontrolled with Dual Therapies: A Non-Interventional, Open-Label, Single-Arm, Prospective Study (RESPONSE Slovenia).

Symptom Improvement with BDP/FF/G Fixed Triple Inhalation Powder in Moderate to Severe COPD Patients Uncontrolled with Dual Therapies: A Non-Interventional, Open-Label, Single-Arm, Prospective Study (RESPONSE Slovenia).

Journal: COPD

Published: June 09, 2026

Assessing the Equitable Use of Formulary Drug Tier Systems: Consequences for Geriatric Patient Population Access and Accessible Medication.

Assessing the Equitable Use of Formulary Drug Tier Systems: Consequences for Geriatric Patient Population Access and Accessible Medication.

Journal: Innovations in pharmacy

Published: June 08, 2026

In uncontrolled asthma, adding glycopyrronium to budesonide-formoterol reduced annualized severe exacerbations.

In uncontrolled asthma, adding glycopyrronium to budesonide-formoterol reduced annualized severe exacerbations.

Journal: Annals of internal medicine

Published: June 01, 2026

AIR and MART approach to asthma treatment.

AIR and MART approach to asthma treatment.

Journal: Drug and therapeutics bulletin

Published: May 12, 2026

Prescriber adherence to asthma treatment guidelines and its impact on symptom control in Ethiopia: a mixed-methods study.

Prescriber adherence to asthma treatment guidelines and its impact on symptom control in Ethiopia: a mixed-methods study.

Journal: Therapeutic advances in respiratory disease

Published: April 03, 2026

Incorporating New Guidelines into School-Based Asthma Management.

Incorporating New Guidelines into School-Based Asthma Management.

Journal: Current allergy and asthma reports

Published: April 01, 2026

Can tiotropium add-on inhalation revolutionize therapy in elderly asthmatic patients? A treatable traits approach towards successful aging.

Can tiotropium add-on inhalation revolutionize therapy in elderly asthmatic patients? A treatable traits approach towards successful aging.

Journal: International journal of clinical pharmacology and therapeutics

Published: March 17, 2026

Formoterol induced mitochondrial biogenesis and PINK1-Parkin mitophagy via activation of β2-adrenergic receptor signaling and downregulation of miR-421/miR-103a in acute kidney injury.

Formoterol induced mitochondrial biogenesis and PINK1-Parkin mitophagy via activation of β2-adrenergic receptor signaling and downregulation of miR-421/miR-103a in acute kidney injury.

Journal: Chemico-biological interactions

Published: March 16, 2026

Maintenance and Reliever Therapy in Pediatric Asthma: A Concise Review of Recent Evidence-Part II.

Maintenance and Reliever Therapy in Pediatric Asthma: A Concise Review of Recent Evidence-Part II.

Journal: Pediatric annals

Published: March 05, 2026

Comparative Effectiveness and Safety of LAMA-LABA Inhalers in Chronic Obstructive Pulmonary Disease.

Comparative Effectiveness and Safety of LAMA-LABA Inhalers in Chronic Obstructive Pulmonary Disease.

Journal: JAMA internal medicine

Published: February 23, 2026

Bioequivalence of budesonide/glycopyrrolate/formoterol fumarate with a next-generation propellant versus hydrofluoroalkane-134a in healthy adults: phase I, randomized, double-blind, single-dose, partial-replicate, three-way cross-over lung exposure and total systemic exposure studies.

Bioequivalence of budesonide/glycopyrrolate/formoterol fumarate with a next-generation propellant versus hydrofluoroalkane-134a in healthy adults: phase I, randomized, double-blind, single-dose, partial-replicate, three-way cross-over lung exposure and total systemic exposure studies.

Journal: Therapeutic advances in respiratory disease

Published: February 12, 2026

Showing 1-12 of 3,184

Last Updated: 06/30/2026